Clinical Trial Update: Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, and preliminary efficacy of BCT194 in healthy volunteers and patients with psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BCT194

Snippet

Sponsor: Novartis | Conditions: Psoriasis | Phase 1 | Status: COMPLETED